Skip to main content

Table 2 Univariate analysis for factors associated with mortality of patients with S. maltophilia bacteremia

From: Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate

Factor

Overall

n (%)

(n = 68)

Death

n (%)

(n = 23)

Resolved

n (%)

(n = 45)

p value§

ICU admission prior to episode

    

 Yes

28 (41.2%)

19 (82.6%)

9 (20%)

 < 0.001**

 No

40 (58.8%)

4 (17.4%)

36 (80%)

Intubation prior to episode

    

 Yes

23 (33.8%)

14 (60.9%)

9 (20.0%)

 

 No

45 (66.2%)

9 (39.1%)

36 (80.0%)

Immunosuppressive therapy

    

 Yes

22 (32.4%)

7 (30.4%)

15 (33.3%)

0.809

 No

46 (67.6%)

16 (69.6%)

30 (66.7%)

Chemotherapy

    

 Yes

20 (29.4%)

7 (30.4%)

13 (28.9%)

0.895

 No

48 (70.6%)

16 (69.6%)

32 (71.1%)

Received meropenem

    

 Yes

27 (39.7%)

15 (65.2%)

12 (26.7%)

 

 No

41 (60.3%)

8 (34.8%)

33 (73.3%)

Organ transplant

    

 Yes

22 (32.4%)

6 (26.1%)

16 (35.6%)

0.430

 No

46 (67.6%)

17 (73.9%)

29 (64.4%)

Steroid therapy

    

 Yes

19 (27.9%)

7 (30.4%)

12 (26.7%)

0.743

 No

49 (72.1%)

16 (69.6%)

33 (73.3%)

Neutropenia

    

 Yes

32 (47.1%)

16 (69.6%)

16 (35.6%)

 

 No

36 (52.9%)

7 (30.4%)

29 (64.4%)

Central line

    

 Yes

66 (97.1%)

23 (100.0%)

43 (95.6%)

0.305

 No

2 (2.9%)

0

2 (4.4%)

Platelet count

    

 < 150

56 (82.4%)

23 (100%)

33 (73.3%)

 

 ≥ 150

12 (17.6%)

0

12 (26.7%)

Positive respiratory culture

    

 Yes

24 (35.3%)

17 (73.9%)

7 (15.6%)

< 0.001**

 No

44 (64.7%)

6 (26.1%)

38 (84.4%)

Treatment with TMP/SMX

    

 Monotherapy

36 (76.6%)

11 (73.3%)

25 (78.1%)

0.718

 Combination

11 (23.4%)

4 (26.7%)

7 (21.9%)

  1. §p value has been calculated using Chi-square test
  2. **Significant at p ≤ 0.05